Cargando…
Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection
Up to 50% of patients initially treated for prostate cancer in a curative intent experience biochemical recurrence, possibly requiring adjuvant treatment. However, salvage treatment decisions, such as lymph node dissection or radiation therapy, are typically based on prostate specific antigen (PSA)...
Autores principales: | Krimphove, Marieke J., Theissen, Lena H., Cole, Alexander P., Preisser, Felix, Mandel, Philipp C., Chun, Felix K.-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Sexual Medicine and Andrology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920066/ https://www.ncbi.nlm.nih.gov/pubmed/30929322 http://dx.doi.org/10.5534/wjmh.180133 |
Ejemplares similares
-
Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
por: Osmonov, Daniar K., et al.
Publicado: (2014) -
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023) -
PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020) -
Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015) -
Role of salvage lymph node dissection in patients previously treated for prostate cancer: systematic review
por: Fantin, João Paulo Pretti, et al.
Publicado: (2020)